Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease
Articolo
Data di Pubblicazione:
2004
Abstract:
T he renin-angiotensin system plays a major role in cardiovascular disease and during the past decade extensive research investigated the possible clinical benefit of the use of angiotensin converting enzyme inhibitors (ACE-I) in different clinical conditions. Accordingly, these agents have been recommended for the treatment of heart failure, hypertension, and acute and chronic myocardial infarction. The aim of this document is to review the rationale and clinical evidence for the use of ACE-I in patients with cardiovascular disease.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
angiotensin; cardiovascular disease; guidelines
Elenco autori:
López Sendón, J; Swedberg, K; Mcmurray, J; Tamargo, J; Maggioni, Ap; Dargie, H; Tendera, M; Waagstein, F; Kjekshus, J; Lechat, P; Torp Pedersen, C; Priori, SILVIA GIULIANA; Alonso García, Ma; Blanc, Jj; Budaj, A; Cowie, M; Dean, V; Deckers, J; Fernández Burgos, E; Lekakis, J; Lindahl, B; Mazzotta, G; Mcgregor, K; Morais, J; Oto, A; Smiseth, Oa; Ardissino, D; Avendano, C; Blomström Lundqvist, C; Clément, D; Drexler, H; Ferrari, R; Fox, Ka; Julian, D; Kearney, P; Klein, W; Köber, L; Mancia, G; Nieminen, M; Ruzillo, W; Simoons, M; Thygesen, K; Tognoni, G; Tritto, I; Wallentin, L; Task Force on ACE inhibitors of the European Society of, Cardiology; Comité de la ESC para la elaboracion de las Guías de Práctica, Clínica
Link alla scheda completa:
Pubblicato in: